Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cannara Biotech Inc (OP: LOVFF ) 0.5372 UNCHANGED Streaming Delayed Price Updated: 2:57 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cannara Biotech Inc < Previous 1 2 Next > Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure July 23, 2024 Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and... Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Reports Q3 2024 Financial Results July 23, 2024 From Cannara Biotech (Québec) Inc. Via GlobeNewswire Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going June 03, 2024 In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable... Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss May 01, 2024 Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68%... Via Benzinga Topics Cannabis Exposures Cannabis This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices December 20, 2023 --News Direct-- Via News Direct Topics Cannabis Exposures Cannabis The 7 Most Undervalued Cannabis Stocks to Buy in December December 14, 2023 These seven cannabis stocks are either undervalued based on traditional metrics, or are undervalued relative to future potential. Via InvestorPlace Topics Cannabis Exposures Cannabis This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices December 07, 2023 Nicholas Sosiak, CFO of Cannara Biotech (TSXV: LOVE.V) (OTCQB: LOVFF) (FRA: 8CB) was recently interviewed by Benzinga. Via Benzinga Topics Cannabis Exposures Cannabis Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis 7 Smoking-Hot 420 Stocks to Buy in 2023 August 17, 2023 A blaze of renewed bullishness may be just around the corner for these seven cannabis plays, making them top 420 stocks to buy. Via InvestorPlace Topics Cannabis Exposures Cannabis Cannabis Stock Movers For August 10, 2023 August 10, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA? July 27, 2023 Cannara Biotech Inc. Via Benzinga Cannabis Stock Gainers And Losers From July 25, 2023 July 25, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 4, 2023 August 04, 2023 Via Benzinga Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking May 04, 2023 Cannara Biotech Inc. Via Benzinga Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details April 24, 2023 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal second quarter 2023 financial results, revealing net revenue of CA$13 million ($9.6 million), a 76% increase, compared to... Via Benzinga Marijuana Stock Movers For August 1, 2023 August 01, 2023 Via Benzinga Olymbec Investments Increases Its Ownership In Cannara Biotech February 10, 2023 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) held its annual shareholder meeting on January 25, 2023. Via Benzinga Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA? January 23, 2023 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal first quarter 2023 financial results for the three-month period ended November 30, 2022, revealing revenue of CA$10.3... Via Benzinga Cannabis Stock Movers For July 27, 2023 July 27, 2023 Via Benzinga Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M November 28, 2022 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ended August 31, 2022,... Via Benzinga Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products September 20, 2022 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB), a Quebec-based, vertically integrated producer of cannabis and derivative product offerings, entered into the British Columbia (BC) market. Via Benzinga Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada August 03, 2022 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) entered into an exclusive brand partnership with Exotic Genetix Ltd. Via Benzinga Cannara Biotech Revenue Grows 41% YoY, Here Are The Details July 27, 2022 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) fiscal Q3 2022 revenue was $10.1 million, a 36% increase from the previous quarter and a 41% increase compared to Q3 2021. Via Benzinga Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking June 02, 2022 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has closed on a $50M credit facility led by BMO Commercial Banking. Via Benzinga Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY April 27, 2022 Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal second quarter 2022 financial and operating results for the three and six-month periods ended February 28, 2022. Via Benzinga The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More December 10, 2021 Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021. Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA December 09, 2021 Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: Via Benzinga Topics Cannabis Exposures Cannabis Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July August 02, 2021 Canadian cannabis stocks took a beating In July, with the Canadian Cannabis LP Index posting a 9.8% loss while continuing the decl... Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue July 29, 2021 Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: Via Benzinga Topics Cannabis Exposures Cannabis The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More July 02, 2021 Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs... Via Benzinga Topics Cannabis Exposures Cannabis < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.